The treatment of complicated and severe malaria

British Medical Bulletin

Volumn 75-76, Issue 1, 2005, Pages 29-47

  Pasvol, Geoffrey ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

Artemether; Artemisinin; Artesunate; Cerebral malaria; Complicated malaria; Quinine; Severe falciparum malaria; Treatment

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; ANTIMALARIAL AGENT; ARTEMETHER; ARTEMISININ; ARTEMISININ DERIVATIVE; ARTESUNATE; BENZODIAZEPINE; BICARBONATE; CIMETIDINE; CINCHONA ALKALOID; CLINDAMYCIN; CORTICOSTEROID; DEXAMETHASONE; DIAZEPAM; DOXYCYCLINE; FANSIDAR; HISTAMINE H2 RECEPTOR ANTAGONIST; IRON CHELATING AGENT; LORAZEPAM; PARACETAMOL; PHENOBARBITAL; QUINIDINE; QUINIDINE GLUCONATE; QUININE; QUININE SULFATE; RANITIDINE; TETRACYCLINE; UNINDEXED DRUG; VITAMIN K GROUP;

ACIDOSIS; ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ANEMIA; ARTIFICIAL VENTILATION; ATAXIA; BLEEDING DISORDER; BLOOD CLOTTING DISORDER; BLOOD EXAMINATION; BLOOD TRANSFUSION; BLURRED VISION; BRAIN MALARIA; COMA; CONSCIOUSNESS DISORDER; CONVULSION; DELAYED DIAGNOSIS; DIALYSIS; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE EXACERBATION; DRUG FATALITY; ELECTROLYTE DISTURBANCE; GASTROINTESTINAL HEMORRHAGE; HEARING IMPAIRMENT; HEART ARRHYTHMIA; HEMODIAFILTRATION; HEMODIALYSIS; HEMOGLOBINURIA; HOSPITAL CARE; HUMAN; HYPERINSULINEMIA; HYPERNATREMIA; HYPEROSMOLARITY; HYPOGLYCEMIA; INTENSIVE CARE UNIT; INTRACRANIAL HYPERTENSION; INTRAVASCULAR HEMOLYSIS; JAUNDICE; KIDNEY FAILURE; LACTIC ACIDOSIS; MALARIA FALCIPARUM; METABOLIC ACIDOSIS; MICROSCOPY; MORTALITY; NAUSEA; PARASITEMIA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RESPIRATION DEPRESSION; RESPIRATORY DISTRESS; REVIEW; REYE SYNDROME; SEIZURE; SHOCK; SPLEEN RUPTURE; SUPERINFECTION; TINNITUS; UNCONSCIOUSNESS; VOMITING;

ANTIMALARIALS; BLOOD TRANSFUSION; HUMANS; MALARIA, CEREBRAL; MALARIA, FALCIPARUM; PARASITOLOGY; RESPIRATION, ARTIFICIAL;

EID: 33750901836     PISSN: 00071420     EISSN: 14718391     Source Type: Journal    
DOI: 10.1093/bmb/ldh059     Document Type: Review

References (48)

1. Snow RW, Guerra CA, Noor AM et al. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005;434:214-17.
2. Bell D, Winstanley P. Current issues in the treatment of uncomplicated malaria in Africa. Br Med Bull 2004;71:29-43.
3. WHO. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 2000;94(Suppl. 1):S1-90.
4. Kochar DK, Saxena V, Singh N et al. Plasmodium vivax malaria. Emerg Infect Dis 2005;11:132-4.
5. Newton CR, Kirkham FJ, Winstanley PA et al. Intracranial pressure in African children with cerebral malaria. Lancet 1991;337:573-6.
6. Silamut K, White NJ. Relation of the stage of parasite development in the peripheral blood to prognosis in severe falciparum malaria. Trans R Soc Trop Med Hyg 1993;87:436-43.
7. Nguyen PH, Day N, Pram TD et al. Intraleucocytic malaria pigment and prognosis in severe malaria. Trans R Soc Trop Med Hyg 1995;89:200-4.
8. Gachot B, Houze S, Le Bras J et al. Possible prognostic significance of a brief rise in parasitaemia following quinine treatment of severe Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 1996;90:388-90.
9. Craig MH, Bredenkamp BL, Williams CH et al. Field and laboratory comparative evaluation of ten rapid malaria diagnostic tests. Trans R Soc Trop Med Hyg 2002;96:258-65.
10. Pasvol G. Management of severe malaria: interventions and controversies. Infect Dis Clin North Am 2005;19:211-40.
11. Maitland K, Nadel S, Pollard AJ et al. Management of severe malaria in children: proposed guidelines for the United Kingdom. BMJ 2005;331:337-43.
12. Planche T, Krishna S. The relevance of malaria pathophysiology to strategies of clinical management. Curr Opin Infect Dis 2005;18:369-75.
13. Njuguna P, Newton C. Management of severe falciparum malaria. J Postgrad Med 2004;50:45-50.
14. Maitland K, Levin M, English M et al. Severe P. falciparum malaria in Kenyan children: evidence for hypovolaemia. QJM 2003;96:427-34.
15. Pasvol G, Newton CR, Winstanley PA et al. Quinine treatment of severe falciparum malaria in African children: a randomized comparison of three regimens. Am J Trop Med Hyg 1991;45:702-13.
16. White NJ, Looareesuwan S, Warrell DA et al. Quinine loading dose in cerebral malaria. Am J Trop Med Hyg 1983;32:1-5.
17. Davis TM, Supanaranond W, Pukrittayakamee S et al. A safe and effective consecutive-infusion regimen for rapid quinine loading in severe falciparum malaria. J Infect Dis 1990;161:1305-8.
18. Phillips RE, Looareesuwan S, Molyneux ME et al. Hypoglycaemia and counterregulatory hormone responses in severe falciparum malaria: treatment with Sandostatin. Q J Med 1993;86:233-40.
19. Bonington A, Davidson RN, Winstanley PA et al. Fatal quinine cardiotoxicity in the treatment of falciparum malaria. Trans R Soc Trop Med Hyg 1996;90:305-7.
20. Bethell DB, Phuong PT, Phuong CX et al. Electrocardiographic monitoring in severe falciparum malaria. Trans R Soc Trop Med Hyg 1996;90:266-9.
21. Phillips RE. Warrell DA, White NJ et al. Intravenous quinidine for the treatment of severe falciparum malaria. Clinical and pharmacokinetic studies. N Engl J Med 1985;312:1273-8.
22. Kremsner PG, Radloff P, Metzger W et al. Quinine plus clindamycin improves chemotherapy of severe malaria in children. Antimicrob Agents Chemother 1995;39:1603-5.
23. ter Kuile F, White NJ, Holloway P et al. Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria. Exp Parasitol 1993;76:85-95.
24. A meta-analysis using individual patient data of trials comparing artemether with quinine in the treatment of severe falciparum malaria. Trans R Soc Trop Med Hyg 2001;95:637-50.
25. Newton PN, Angus BJ, Chierakul W et al. Randomized comparison of artesunate and quinine in the treatment of severe falciparum malaria. Clin Infect Dis 2003;37:7-16.
26. Hien TT, Davis TM, Chuong LV et al. Comparative pharmacokinetics of intramuscular artesunate and artemether in patients with severe falciparum malaria. Antimicrob Agents Chemother 2004;48:4234-9.
27. Dondorp A, Nosten F, Stepniewska K et al. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 2005;366:717-25.
28. Roze E, Thiebaut MM, Mazevet D et al. Neurologic sequelae after severe falciparum malaria in adult travelers. Eur Neurol 2001;46:192-7.
29. Warrell DA, Looareesuwan S, Warrell MJ et al. Dexamethasone proves deleterious in cerebral malaria. A double-blind trial in 100 comatose patients. N Engl J Med 1982;306:313-19.
30. Hoffman SL, Rustama D, Punjabi NH et al. High-dose dexamethasone in quinine-treated patients with cerebral malaria: a double-blind, placebo-controlled trial. J Infect Dis 1988;158:325-31.
31. Newton CR, Crawley J, Sowumni A et al. Intracranial hypertension in Africans with cerebral malaria. Arch Dis Child 1997;76:219-26.
32. Crawley J, Waruiru C, Mithwani S et al. Effect of phenobarbital on seizure frequency and mortality in childhood cerebral malaria: a randomised, controlled intervention study. Lancet 2000;355:701-6.
33. Marsh K, Forster D, Waruiru C et al. Indicators of life-threatening malaria in African children. N Engl J Med 1995;332:1399-404.
34. Day NP, Phu NH, Mai NT et al. The pathophysiologic and prognostic significance of acidosis in severe adult malaria. Crit Care Med 2000;28:1833-40.
35. English M, Waruiru C, Marsh K. Transfusion for respiratory distress in life-threatening childhood malaria. Am J Trop Med Hyg 1996;55:525-30.
36. Hilton PJ, Taylor J, Forni LG et al. Bicarbonate-based haemofiltration in the management of acute renal failure with lactic acidosis. QJM 1998;91:279-83.
37. Day NP, Phu NH, Bethell DP et al. The effects of dopamine and adrenaline infusions on acid-base balance and systemic haemodynamics in severe infection. Lancet 1996;348:219-23.
38. Ustianowski A, Schwab U, Pasvol G. Case report: severe acute symptomatic hyponatraemia in falciparum malaria. Trans R Soc Trop Med Hyg 2002;96:647-8.
39. Tran TH, Day NP, Ly VC et al. Blackwater fever in southern Vietnam: a prospective descriptive study of 50 cases. Clin Infect Dis 1996;23:1274-81.
40. Phu NH, Hien TT, Mai NT et al. Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam. N Engl J Med 2002;347:895-902.
41. Berkley J, Mwarumba S, Bramham K et al. Bacteraemia complicating severe malaria in children. Trans R Soc Trop Med Hyg 1999;93:283-6.
42. Clemens R, Pramoolsinsap C, Lorenz R et al. Activation of the coagulation cascade in severe falciparum malaria through the intrinsic pathway. Br J Haematol 1994;87:100-5.
43. Bruneel F, Hocqueloux L, Alberti C et al. The clinical spectrum of severe imported falciparum malaria in the intensive care unit: report of 188 cases in adults. Am J Respir Crit Care Med 2003;167:684-9.
44. Phillips RE, Pasvol G. Anaemia of Plasmodium falciparum malaria. Baillieres Clin Haematol 1992;5:315-30.
45. Powell VI, Grima K. Exchange transfusion for malaria and Babesia infection. Transfus Med Rev 2002;16:239-50.
46. Riddle MS, Jackson JL, Sanders JW et al. Exchange transfusion as an adjunct therapy in severe Plasmodium falciparum malaria: a meta-analysis. Clin Infect Dis 2002;34:1192-8.
47. Wilkinson RJ, Brown JL, Pasvol G et al. Severe falciparum malaria: predicting the effect of exchange transfusion. QJM 1994;87:553-7.
48. Zhang Y, Telleria L, Vinetz JM et al. Erythrocytapheresis for Plasmodium falciparum infection complicated by cerebral malaria and hyperparasitemia. J Clin Apheresis 2001;16:15-18.